Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › CA › Northridge › NPI 1417089350
Hospital

Dignity Community Care

Dignity Community Care was paid $58.90M by Medicaid between Jan 2018 and Dec 2024, across 255 billing codes. Its largest line is 0450, Emergency room services — 28% of everything it billed.

33Billing provider infoDIGNITY COMMUNITY CARE
NORTHRIDGE, CA 91325
33aNPI1417089350assigned 03/09/2007
28Total paid$58.90M
24GClaims1,140,822
24DCodes billed255
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Rehabilitation Hospital Unit providers in California

Rank by total paid#4 of 22
Median peer was paid$308K
This provider vs. median191×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018171,014$6.35M
2019165,152$8.98M
2020128,553$8.49M
2021144,405$8.33M
2022165,681$10.48M
2023192,576$9.17M
2024incomplete173,441$7.10M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
0450 Emergency room services 28% 121,568 109,187 $16.72M
0250 5.2% 34,333 19,316 $3.06M
80048 Basic metabolic panel (calcium, ionized) 4.3% 45,663 42,122 $2.56M
70450 Computed tomography, head or brain; without contrast material 4.2% 11,494 11,151 $2.49M
99199 Unlisted special service, procedure or report 4.2% 11,544 10,817 $2.48M
74177 Computed tomography, abdomen and pelvis; with contrast material 3.5% 6,307 6,134 $2.06M
99281 Emergency department visit for the evaluation and management, self-limited or minor 2.9% 16,770 13,712 $1.70M
80053 Comprehensive metabolic panel 2.8% 27,734 25,833 $1.64M
71045 Radiologic examination, chest; single view 2.1% 31,409 29,851 $1.26M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2.0% 22,928 21,179 $1.18M
74176 Computed tomography, abdomen and pelvis; without contrast material 1.9% 5,527 5,387 $1.14M
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 1.9% 8,421 7,925 $1.14M
243 more codes
99285 Emergency room visit (most serious) 1.9% 4,800 $1.12M
0301 1.7% 4,721 $974K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.6% 65,942 $960K
99284 Emergency room visit (serious) 1.5% 6,867 $904K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.5% 33,976 $897K
76705 Ultrasound, abdominal, real time with image documentation; limited 1.2% 7,373 $726K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1.2% 13,122 $720K
71046 Radiologic examination, chest; 2 views 1.0% 8,515 $595K
72125 Computed tomography, cervical spine; without contrast material 1.0% 3,688 $593K
96375 Therapeutic injection; each additional sequential IV push <1% 16,182 $578K
Z7502 <1% 14,739 $553K
84484 <1% 26,753 $516K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 11,290 $474K
J3490 Unclassified drugs <1% 35,894 $458K
99283 Emergency room visit (moderate) <1% 3,650 $401K
80076 <1% 18,672 $368K
71275 Computed tomographic angiography, chest, with contrast material <1% 1,535 $366K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 11,940 $333K
84703 <1% 20,423 $330K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 3,673 $323K
83690 <1% 25,871 $321K
36415 Collection of venous blood by venipuncture <1% 47,215 $318K
81001 <1% 29,190 $296K
93971 <1% 2,238 $286K
87086 Culture, bacterial; quantitative colony count, urine <1% 12,034 $269K
76830 Ultrasound, transvaginal <1% 2,426 $268K
76801 <1% 2,229 $255K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 487 $214K
73130 <1% 2,316 $205K
73562 <1% 2,514 $205K
73030 <1% 2,548 $204K
87040 <1% 9,173 $193K
72100 <1% 1,922 $191K
73610 <1% 2,586 $186K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 714 $181K
85730 <1% 17,112 $181K
73630 <1% 2,560 $169K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 2,847 $167K
0762 <1% 1,077 $163K
83880 <1% 6,546 $159K
70486 <1% 865 $149K
85610 <1% 18,979 $142K
83605 <1% 9,315 $140K
0214 <1% 182 $137K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 9,391 $136K
96361 Intravenous infusion, hydration; each additional hour <1% 4,091 $130K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 6,112 $128K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 2,427 $122K
72131 <1% 584 $120K
73110 <1% 1,552 $120K
93970 <1% 611 $117K
81003 <1% 14,802 $117K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 806 $115K
87631 <1% 849 $111K
85027 <1% 9,642 $106K
J7030 Infusion, normal saline solution , 1000 cc <1% 22,034 $102K
82962 <1% 5,261 $100K
76775 <1% 1,055 $92K
0270 <1% 16,567 $91K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 2,172 $90K
86885 <1% 3,575 $81K
73080 <1% 927 $68K
73590 <1% 1,056 $67K
87070 <1% 2,460 $60K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,348 $60K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 13,623 $59K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 1,074 $57K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 1,178 $54K
90715 <1% 2,037 $53K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 2,175 $53K
0720 <1% 1,015 $52K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 2,248 $52K
J2270 Injection, morphine sulfate, up to 10 mg <1% 11,024 $51K
87186 <1% 3,353 $50K
84702 <1% 2,445 $50K
70496 <1% 176 $47K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 275 $46K
73564 <1% 494 $46K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 10,808 $46K
0272 <1% 711 $46K
0360 <1% 42 $44K
73140 <1% 697 $43K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 4,614 $41K
76870 <1% 283 $40K
73502 <1% 750 $38K
0258 <1% 1,689 $37K
83735 <1% 4,738 $37K
72040 <1% 437 $36K
74018 <1% 564 $36K
96376 <1% 2,827 $34K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 335 $33K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 349 $32K
0710 <1% 644 $30K
86900 <1% 4,304 $29K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 5,451 $28K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 4,009 $28K
71250 <1% 230 $28K
86901 <1% 4,304 $28K
84443 Thyroid stimulating hormone (TSH) <1% 1,894 $27K
Z7610 <1% 5,001 $27K
85379 <1% 2,026 $26K
70551 Magnetic resonance imaging, brain; without contrast material <1% 156 $26K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 863 $25K
73090 <1% 580 $25K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 508 $25K
70498 <1% 172 $24K
J1815 Injection, insulin, per 5 units <1% 751 $24K
12001 <1% 292 $24K
85007 <1% 3,369 $23K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 2,331 $19K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 2,114 $18K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 322 $18K
72170 <1% 738 $17K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 179 $16K
87430 <1% 1,699 $15K
Z9725 <1% 348 $15K
12011 <1% 110 $14K
99213 Doctor's office visit, returning patient (routine) <1% 378 $14K
A9270 Non-covered item or service <1% 8,498 $14K
J2060 Injection, lorazepam, 2 mg <1% 3,797 $13K
71101 <1% 93 $12K
J1170 Injection, hydromorphone, up to 4 mg <1% 2,836 $12K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 3,270 $12K
0160 <1% 218 $12K
87428 <1% 122 $11K
0949 <1% 99 $11K
10060 <1% 133 $10K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 332 $10K
93458 <1% 40 $10K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 3,047 $9K
G0378 Hospital observation service, per hour <1% 78 $9K
82150 <1% 1,195 $9K
87077 <1% 890 $9K
87147 <1% 946 $9K
87506 <1% 28 $8K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 2,412 $8K
84145 <1% 516 $7K
12002 <1% 107 $7K
87088 <1% 930 $6K
29125 <1% 108 $6K
80061 Lipid panel <1% 817 $6K
A4649 Surgical supply; miscellaneous <1% 1,843 $6K
82550 <1% 901 $6K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 932 $6K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 816 $6K
86140 <1% 1,371 $5K
87210 <1% 360 $5K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 692 $5K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 1,975 $4K
72128 <1% 14 $4K
73552 <1% 68 $4K
73060 <1% 97 $3K
85652 <1% 542 $3K
85018 <1% 1,339 $3K
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) <1% 21 $3K
J1644 Injection, heparin sodium, per 1000 units <1% 1,189 $3K
A9150 Non-prescription drugs <1% 4,396 $3K
82805 <1% 97 $2K
99152 <1% 197 $2K
84100 <1% 654 $2K
83036 Hemoglobin; glycosylated (A1C) <1% 495 $2K
J7050 Infusion, normal saline solution, 250 cc <1% 777 $2K
97162 <1% 118 $2K
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 111 $2K
87420 <1% 212 $2K
84439 <1% 341 $2K
J2704 Injection, propofol, 10 mg <1% 90 $2K
82010 <1% 182 $2K
59025 Fetal non-stress test <1% 23 $2K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 243 $2K
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals <1% 28 $2K
72070 <1% 14 $1K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 26 $1K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 574 $1K
S0164 Injection, pantoprazole sodium, 40 mg <1% 197 $1K
J0360 Injection, hydralazine hcl, up to 20 mg <1% 258 $1K
29515 <1% 26 $1K
76770 <1% 43 $1K
J1630 Injection, haloperidol, up to 5 mg <1% 221 $998.54
76641 <1% 13 $939.80
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 76 $862.57
82375 <1% 97 $856.29
96367 <1% 23 $838.18
J7120 Ringers lactate infusion, up to 1000 cc <1% 179 $781.41
0370 <1% 173 $685.77
71020 <1% 37 $674.19
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 116 $656.63
82248 <1% 71 $620.38
Z7500 <1% 17 $579.70
83050 <1% 97 $551.29
J0690 Injection, cefazolin sodium, 500 mg <1% 133 $548.32
J3370 Injection, vancomycin hcl, 500 mg <1% 47 $478.24
82607 <1% 88 $396.75
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 16 $364.67
J1171 Injection, hydromorphone, 0.1 mg <1% 22 $324.39
99153 Mod sedat endo service >5yrs <1% 55 $319.61
L3807 Wrist hand finger orthosis, without joint(s), prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise <1% 12 $309.41
S0028 Injection, famotidine, 20 mg <1% 939 $276.32
0760 <1% 20 $212.44
82140 <1% 13 $156.12
82728 <1% 54 $138.61
J1650 Injection, enoxaparin sodium, 10 mg <1% 21 $136.68
0278 <1% 27 $127.51
86780 <1% 14 $126.92
J1940 Injection, furosemide, up to 20 mg <1% 35 $126.02
J3475 Injection, magnesium sulfate, per 500 mg <1% 12 $120.40
J2274 Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg <1% 16 $105.55
84550 <1% 69 $93.40
S0020 Injection, bupivicaine hydrochloride, 30 ml <1% 30 $61.89
0324 <1% 560 $60.54
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 14 $57.51
86308 <1% 29 $54.48
0300 <1% 648 $51.59
J1953 Injection, levetiracetam, 10 mg <1% 14 $46.77
83540 <1% 58 $45.53
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 71 $43.09
0305 <1% 712 $28.35
83550 <1% 26 $15.34
0306 <1% 487 $13.60
82040 <1% 13 $9.70
87081 <1% 14 $4.54
99072 <1% 95 $4.00
A4218 Sterile saline or water, metered dose dispenser, 10 ml <1% 28 $3.36
0307 0% 275 $0.00
S9445 Patient education, not otherwise classified, non-physician provider, individual, per session 0% 1,930 $0.00
0310 0% 142 $0.00
0420 0% 127 $0.00
77063 Screening digital breast tomosynthesis, bilateral 0% 14 $0.00
0352 0% 99 $0.00
J2785 Injection, regadenoson, 0.1 mg 0% 13 $0.00
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 0% 15 $0.00
Q4051 Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies) 0% 18 $0.00
27502 0% 15 $0.00
83615 0% 14 $0.00
0351 0% 12 $0.00
0730 0% 240 $0.00
0402 0% 69 $0.00
0510 0% 15 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 29 $0.00
77067 Screening mammography, bilateral, including computer-aided detection 0% 14 $0.00
0489 0% 13 $0.00
0302 0% 13 $0.00
93017 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBROWN, DOUGLAS (CHIEF FINANCIAL OFFICER)
Parent organizationCATHOLIC HEALTH INITIATIVES
Same official

Other billing entities under BROWN, DOUGLAS

Full network →
ProviderLocationPaid
Bilingual Pediatric TherapiesOklahoma City, OK$9.94M
Hope for TulsaTulsa, OK$8.27M
Mini Miracles Pediatric Therapy, PLLCJohnson City, TN$7.18M
Addiction Recovery Center of VirginiaWilliamsburg, VA$6.05M
Portable Medical Diagnostics LLCJackson, MS$1.44M
Douglas C. Brown, MD, a Medical CorporationMonroe, LA$816K
Portable Medical Diagnostics LLCIrvington, AL$5K
Lakeside Med, LLCFrederick, MD$3K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.